Starling Oncology, Inc. (STLN)
3.50
-0.25
(-6.67%)
USD |
NASDAQ |
Nov 13, 16:00
3.48
-0.02
(-0.57%)
After-Hours: 19:59
Starling Oncology Shareholders Equity (Quarterly) : -37.36M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -37.36M |
| June 30, 2026 | -24.91M |
| March 31, 2026 | -16.28M |
| December 31, 2025 | -15.72M |
| September 30, 2025 | -12.27M |
| June 30, 2025 | -8.985M |
| March 31, 2025 | 5.069M |
| December 31, 2024 | 3.589M |
| September 30, 2024 | 15.48M |
| June 30, 2024 | 29.21M |
| March 31, 2024 | 41.30M |
| December 31, 2023 | 57.02M |
| September 30, 2023 | 71.85M |
| June 30, 2023 | 84.72M |
| Date | Value |
|---|---|
| March 31, 2023 | 98.41M |
| December 31, 2022 | 123.18M |
| September 30, 2022 | 127.93M |
| June 30, 2022 | 123.98M |
| March 31, 2022 | 132.00M |
| December 31, 2021 | 104.16M |
| September 30, 2021 | 205.10M |
| June 30, 2021 | 205.53M |
| March 31, 2021 | 211.65M |
| December 31, 2020 | 28.10M |
| September 30, 2020 | 224.90M |
| June 30, 2020 | 225.04M |
| March 31, 2020 | 225.15M |
| December 31, 2019 | 0.0227M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Astrana Health, Inc. | 856.62M |
| Agilon Health, Inc. | 280.88M |
| Nakamoto, Inc. | 324.28M |
| American Oncology Network, Inc. | -- |
| Regional Health Properties, Inc. | 2.082M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 187.77M |
| Total Liabilities (Quarterly) | 225.13M |
| Debt to Equity Ratio | -2.750 |
| Current Ratio | 1.113 |
| Net Debt Paydown Yield | 0.01% |